首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于调强放疗的鼻咽癌分期探讨
引用本文:曾雷,龚晓昌,敖帆,汤轶强,舒禹先,万桂芬,肖芸,廖瑜露,黄敏,谢琛,蒋春灵,李金高.基于调强放疗的鼻咽癌分期探讨[J].中华放射肿瘤学杂志,2015,24(3):285-288.
作者姓名:曾雷  龚晓昌  敖帆  汤轶强  舒禹先  万桂芬  肖芸  廖瑜露  黄敏  谢琛  蒋春灵  李金高
作者单位:330029 南昌,江西省肿瘤医院放疗科
摘    要:Objective To evaluate the 7th edition of the International Union against Cancer/American Joint Committee on Cancer (UICC/AJCC) staging system for nasopharyngeal carcinoma (NPC), and to provide a basis for its further revision. Methods Three hundred and twenty-three patients who were pathologically diagnosed with NPC (without distant metastasis) and received radical intensity-modulated radiotherapy (IMRT) in our hospital from 2005 to 2011 were enrolled as subjects. All patients were staged according to the 7th edition of the UICC/AJCC staging system. The overall survival (OS), local recurrence-free survival (LRFS), and distant metastasis-free survival (DMFS) rates were calculated using the Kaplan-Meier method, and pairwise comparisons were made by the log-rank test. Multivariate prognostic analyses were performed using the Cox regression model. Results The 5-year sample size was 45. There were no significant differences in 5-year LRFS between stages T1 and T2, as well as between stages T2 and T3(P=0.055;P=0.746). The current stages T2, T3, and T4 with only medial pterygoid muscle were combined into stage T2, and the rest of stage T4 were down-staged to stage T3. In the new T staging system, the LRFS curves of stages T1, T2, and T3 were substantially separated. There were no significant differences in 5-year DMFS between stage N2 and N3a, between stage N2 and N3b, and between stages N3a and N3b (P=0.272;P=0.063;P=0.810). Multivariate analyses demonstrated that cervical lymph node metastasis was the only independent prognostic factor for DMFS (P=0.037). The current stage N3a with cervical lymph node metastasis on one side was down-staged to stage N1, and the current stage N3a with cervical lymph node metastasis on both sides to stage N2. In the new N staging system, the DMFS curves of stages N0, N1, N2, and N3 were substantially separated. There were no significant differences in 5-year OS between stages I and II, as well as between stages III and IVa (P=0.434;P=0.951). The current stages T1N0-1, T2N0-1, T1-3N2/T3N0-1, and T1-3N3 were classified into stage Ia, Ib, II, and III, respectively. In the new staging system, the 5-year OS curves of stages Ia, Ib, II, and III were substantially separated. Conclusions There are several deficiencies in the 7th edition of the UICC/AJCC staging system. The proposed new staging system can achieve a better prognosis, though further validations with a larger sample size are needed.
DOI:10.3760/cma.j.issn.1004-4221.2015.03.014
作者单位:330029 南昌,江西省肿瘤医院放疗科
通信作者:李金高,Email:lijingao@hotmail.com

关 键 词:鼻咽肿瘤/调强放射疗法  分期  预后  

Evaluation of staging system for nasopharyngeal carcinoma based on intensity-modulated radiotherapy
Zeng Lei,Gong Xiaochang,Ao Fan,Tang Yiqiang,Shu Yuxian,Wan Guifen,Xiao Yun,Liao Yulu,Huang Min,Xie Chen,Jiang Chunling,Li Jingao.Evaluation of staging system for nasopharyngeal carcinoma based on intensity-modulated radiotherapy[J].Chinese Journal of Radiation Oncology,2015,24(3):285-288.
Authors:Zeng Lei  Gong Xiaochang  Ao Fan  Tang Yiqiang  Shu Yuxian  Wan Guifen  Xiao Yun  Liao Yulu  Huang Min  Xie Chen  Jiang Chunling  Li Jingao
Institution:Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang 330029, China
Abstract:
Keywords:Nasopharyngeal neoplasms/intensity-modulated radiotherapy  TNM staging  Prognosis

点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号